Jasper Therapeutics (JSPR) Interest Expenses (2019 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Interest Expenses of $496000.0 for Q4 2025, up 68.71% year-over-year from $294000.0 in Q4 2024, and up 801.82% quarter-over-quarter from $55000.0 in Q3 2025.
Jasper Therapeutics (JSPR) Interest Expenses (2019 - 2025) Analysis & Trends
Jasper Therapeutics' Interest Expenses history runs 7 years deep, the most recent figure standing at $496000.0 for Q4 2025.
- In Q4 2025, Interest Expenses rose 68.71% year-over-year to $496000.0; the TTM figure through Dec 2025 stood at $1.4 million (up 58.01% YoY), while the FY2025 annual figure was $1.8 million, down 72.41% from the prior year.
- Interest Expenses for Q4 2025 stood at $496000.0, up from $55000.0 in the prior quarter.
- The five-year high for Interest Expenses was $5.0 million in Q1 2022, with the low at -$153000.0 in Q4 2021.
- The 5-year median for Interest Expenses is $478000.0 (2024), against an average of $1.1 million.
- The sharpest annual moves came in 2021 and 2022: Interest Expenses tumbled 191.62% in 2021, then soared 2253.08% in 2022.
- Jasper Therapeutics' Interest Expenses stood at -$153000.0 in 2021, then surged by 652.94% to $846000.0 in 2022, then sank by 66.31% to $285000.0 in 2023, then climbed by 3.16% to $294000.0 in 2024, then soared by 68.71% to $496000.0 in 2025.
- Business Quant data shows JSPR's Interest Expenses at $496000.0 in Q4 2025, $55000.0 in Q3 2025, and $2.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | Jasper Therapeutics | 20.06 Mn | 20.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 496,000.00 |
| Dec 31, 2025 | 496,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 137,000.00 |
| Mar 31, 2025 | 137,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Sep 30, 2024 | 3.87 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 478,000.00 |
| Jun 30, 2024 | 478,000.00 |
| Mar 31, 2024 | 709,000.00 |
| Mar 31, 2024 | 709,000.00 |
| Dec 31, 2023 | 285,000.00 |
| Dec 31, 2023 | 285,000.00 |
| Sep 30, 2023 | 3.37 Mn |
| Sep 30, 2023 | 3.37 Mn |